Landmark pancreatic cancer drug keeps patients alive for twice as long The Washington Post

The highly anticipated results of a clinical trial for the pill, daraxonrasib, have been released, giving doctors hope for treating the stubbornly lethal disease. May 31, 2026 at 8:00 a.m. EDTYester… [+19 chars]Read More